Translations:Glimepiride/6/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
FuzzyBot (talk | contribs)
Importing a new version from external source
Tags: Mobile edit Mobile web edit
 
(No difference)

Latest revision as of 22:53, 13 March 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Glimepiride)
<!-- Chemical data -->
| IUPAC_name        = 3-Ethyl-4-methyl-''N''-[2-(4-<nowiki/>{[(''trans''-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1''H''-pyrrole-1-carboxamide
| C                  = 24
| H                  = 34
| N                  = 4
| O                  = 5
| S                  = 1
| smiles            = O=C3C(/CC)=C(/C)CN3C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2
| StdInChI_Ref      = {{stdinchicite|correct|chemspider}}
| StdInChI          = 1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)/t16-,19-
| StdInChIKey_Ref    = {{stdinchicite|correct|chemspider}}
| StdInChIKey        = WIGIZIANZCJQQY-RUCARUNLSA-N
| melting_point      = 207
}}
<!-- Definition and medical uses -->
'''Glimepiride''' is an [[antidiabetic medication]] within the [[sulfonylurea]] class, primarily prescribed for the management of  [[type 2 diabetes]]. It is regarded as a second-line option compared to [[metformin]], due to metformin's well-established safety and efficacy. Use of glimepiride is recommended in conjunction with [[Lifestyle modification|lifestyle modifications]] such as diet and exercise. It is taken by mouth, reaching a peak effect within three hours and lasting for about a day.

| IUPAC_name = 3-Ethyl-4-methyl-N-[2-(4-{[(trans-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide | C = 24 | H = 34 | N = 4 | O = 5 | S = 1 | smiles = O=C3C(/CC)=C(/C)CN3C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2 | StdInChI_Ref =  checkY | StdInChI = 1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)/t16-,19- | StdInChIKey_Ref =  checkY | StdInChIKey = WIGIZIANZCJQQY-RUCARUNLSA-N | melting_point = 207 }} Glimepiride is an antidiabetic medication within the sulfonylurea class, primarily prescribed for the management of type 2 diabetes. It is regarded as a second-line option compared to metformin, due to metformin's well-established safety and efficacy. Use of glimepiride is recommended in conjunction with lifestyle modifications such as diet and exercise. It is taken by mouth, reaching a peak effect within three hours and lasting for about a day.